Japanese drug maker R-Tech Ueno has sued Apotex for patent infringement after the Canadian-based pharmaceutical company allegedly applied to create a generic version of one of its eye treatment drugs.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Apotex, R-Tech Ueno, patent infringement, ANDA, FDA, glaucoma
